Anteris Technologies Ltd

ASX:AVR Stock Report

Market Cap: AU$419.4m

Anteris Technologies Past Earnings Performance

Past criteria checks 0/6

Anteris TechnologiesDie Erträge des Sektors -32% sind im Durchschnitt pro Jahr zurückgegangen, während die Erträge des Sektors Medical Equipment growing auf 7.2% pro Jahr stiegen. Die Einnahmen sind declining mit einer durchschnittlichen Rate von 21.7% pro Jahr gesunken.

Key information

-34.8%

Earnings growth rate

3.1%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate-39.0%
Return on equity-240.4%
Net Margin-1,637.9%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Increases to CEO Compensation Might Be Put On Hold For Now at Anteris Technologies Ltd (ASX:AVR)

Jul 08
Increases to CEO Compensation Might Be Put On Hold For Now at Anteris Technologies Ltd (ASX:AVR)

Increases to Anteris Technologies Ltd's (ASX:AVR) CEO Compensation Might Cool off for now

May 07
Increases to Anteris Technologies Ltd's (ASX:AVR) CEO Compensation Might Cool off for now

Does Anteris Technologies' (ASX:AVR) CEO Salary Compare Well With The Performance Of The Company?

Feb 21
Does Anteris Technologies' (ASX:AVR) CEO Salary Compare Well With The Performance Of The Company?

Anteris Technologies Ltd (ASX:AVR) Insiders Have Been Selling

Dec 10
Anteris Technologies Ltd (ASX:AVR) Insiders Have Been Selling

Revenue & Expenses Breakdown
Beta

How Anteris Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:AVR Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 234-674623
30 Sep 234-604320
30 Jun 234-523917
31 Mar 235-483715
31 Dec 225-443413
30 Sep 226-403112
30 Jun 227-352711
31 Mar 227-292310
31 Dec 218-23198
30 Sep 217-21187
30 Jun 216-20166
31 Mar 217-17165
31 Dec 207-15175
30 Sep 209-8214
30 Jun 20100264
31 Mar 2014-3284
31 Dec 1917-6303
30 Sep 1920-15303
30 Jun 1924-24303
31 Mar 1925-24303
31 Dec 1826-24303
31 Dec 1723-17261
30 Jun 1722-12202
31 Mar 1721-15212
31 Dec 1620-18213
30 Sep 1617-21234
30 Jun 1614-24245
31 Mar 1613-26235
31 Dec 1512-27234
30 Sep 1511-26213
30 Jun 1510-25193
31 Mar 159-21172
31 Dec 149-17152
30 Sep 148-12132
30 Jun 148-7112
31 Mar 148-4102
31 Dec 138-191
30 Sep 138-181
30 Jun 137-271

Qualität der Erträge: AVR ist derzeit unrentabel.

Wachsende Gewinnspanne: AVR ist derzeit unrentabel.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Ergebnisentwicklung: AVR ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 32% pro Jahr zugenommen.

Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von AVR verglichen werden, da das Unternehmen derzeit nicht profitabel ist.

Erträge im Vergleich zur Industrie: AVR ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Medical Equipment (-3%) erschwert.


Return on Equity

Hohe Eigenkapitalrendite: AVR hat eine negative Eigenkapitalrendite (-242.32%), da es derzeit unrentabel ist.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.